Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Beauchemin
Claude Beauchemin, Quebec CA
| Patent application number | Description | Published |
|---|---|---|
| 20110213744 | SYSTEMS AND METHODS FOR ASSET CONDITION MONITORING IN ELECTRIC POWER SUBSTATION EQUIPMENT - Certain embodiments of the invention may include systems and methods for asset condition monitoring in electrical power substation equipment. According to an example embodiment of the invention, a method is provided for detecting behavior in electrical substation equipment. The method may include receiving realtime data associated with a plurality of parameters associated with the substation equipment, storing at least a portion of the realtime data over a period of time, wherein the stored data comprises historical data, comparing the realtime and historical data, and generating a report based at least in part on a comparison of the realtime data and historical data. | 09-01-2011 |
Patrick Beauchemin, Pointe-Claire CA
| Patent application number | Description | Published |
|---|---|---|
| 20100225666 | DIGITAL OPTICAL COMPARATOR - A digital optical comparator has a holder for a part under study. A light source illuminates the part and casts an image of the part onto a camera, which is provided with a lens. The image captured by the camera is displayed on a screen, and a drawing of the part is overlaid on the image of the part. Thus, defects in manufacturing can be easily and readily identified. In addition, a determination of whether the part is manufactured within tolerances can also be visually determined. | 09-09-2010 |
Sophie Beauchemin, Quebec CA
| Patent application number | Description | Published |
|---|---|---|
| 20090240027 | INTERMEDIATES FOR MACROCYCLIC COMPOUNDS - The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: | 09-24-2009 |
| 20110105389 | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same - The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (GRLN, growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and/or variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as antagonists or inverse agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, obesity and obesity-associated disorders, appetite or eating disorders, addictive disorders, cardiovascular disorders, gastrointestinal disorders, genetic disorders, hyperproliferative disorders, central nervous system disorders and inflammatory disorders. | 05-05-2011 |